Clin2
NCT06422208Possibly a fitEnrolling by invitation

Parkinson's cell transplant trial using your own cells

Parkinson Disease

Part of Brain & nervous system clinical trials.

This trial tests whether transplanting special dopamine-producing cells made from a patient's own skin cells can help treat Parkinson's disease. It is for people who have had Parkinson's for at least 5 years and still respond well to medication.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
6 people
Ages
55 years to 80 years
Study type
Interventional

Who can take part

  • You have had Parkinson's disease for at least 5 years and your symptoms improve with medication by at least 30%.
  • You are between 55 and 80 years old.
  • You have not had any brain surgeries, including deep brain stimulation.
  • You have no major memory or thinking problems, and no untreated depression or serious mental health conditions.
  • You have no active cancer, serious heart or blood vessel disease, or uncontrolled diabetes.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06687837Recruiting· Phase 1
Stem cell therapy for Parkinson's disease

This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.

Boston, Massachusetts
NCT07102342Recruiting· Phase 1/Phase 2
Cell therapy for Parkinson's disease

This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.

New York, New York
NCT06344026Enrolling by invitation· Phase 1
A cell therapy trial for Parkinson's disease

This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.

Tucson, Arizona
NCT06167681Recruiting· Phase 1/Phase 2
Cell Therapy NouvNeu001 for Parkinson's Disease

This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.

Beijing, Beijing Municipality
NCT07212088Not yet recruiting· Phase 1
Brain cell injection for Parkinson's disease

This trial tests whether injecting special cells into the brain can improve Parkinson's symptoms. It is for people who have had Parkinson's for at least 5 years, take levodopa but still have times when the medication wears off or causes uncontrolled movements.

Hangzhou, Zhejiang
NCT07572071Recruiting· Phase 1
Cell transplant study for moderate Parkinson's disease

This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.

Shiraz

Hear when a new Parkinson Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.